Home » News » 02/06 » Abbott Laboratories suspended from ABPI

Abbott Laboratories suspended from ABPI

Date published: 13/02/2006

Abbott Laboratories has been suspended from the Association of the British Pharmaceutical Industry (ABPI) for breaches of the code of practice. The initial suspension of six months stems from complaints about inappropriate hospitality for health professionals.

ABPI president Vincent Lawton said: "The pharmaceutical industry strives to maintain the highest possible ethical standards in all its dealing with healthcare professionals. The breaches that have been identified are viewed in a very serious light, and this is reflected in the suspension ? a sanction that we have not needed to apply for many years.

"However, it is reassuring to note that Abbott also recognises the seriousness of the breaches, and has taken action to prevent their recurrence."

Abbott has stated that it was aware of the problem before the complaint arose and had undertaken an investigation and a review of procedures. It added that the employees involved had left the company. The complaint made in 2005, referring to actions in 2004, concerned hospitality trips, including one to greyhound racing in Manchester, where no records of who attended or what the meetings were about were kept.

© Adfero Ltd

Disclaimer

AllAboutMedicalSales excludes any warranty, express or implied, as to the quality, accuracy, timeliness, completeness or fitness for a particular purpose of this briefing. AllAboutMedicalSales will not be liable for any claims, penalties, losses, damages, costs, or expenses arising from the use of or inability to use this briefing or from any unauthorised access to or alteration of the Briefing. AllAboutMedicalSales makes no warranty that the contents of this briefing are compatible with all computer systems and browsers.